![Karl Kelley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Karl Kelley
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
RAIsonance, Inc.
![]() RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Directeur/Bestuurslid | - | - |
Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Karl Kelley
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
RAIsonance, Inc.
![]() RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Technology Services |
- Beurs
- Insiders
- Karl Kelley
- Ervaring